Compare BXSL & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BXSL | BCPC |
|---|---|---|
| Founded | 2018 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.8B |
| IPO Year | 2018 | 1995 |
| Metric | BXSL | BCPC |
|---|---|---|
| Price | $24.41 | $165.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $27.31 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 2.6M | 143.0K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | ★ 12.96% | 0.59% |
| EPS Growth | N/A | ★ 20.87 |
| EPS | 2.46 | ★ 4.75 |
| Revenue | N/A | ★ $799,023,000.00 |
| Revenue This Year | $1.27 | $8.47 |
| Revenue Next Year | N/A | $4.89 |
| P/E Ratio | ★ $9.70 | $34.14 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $23.30 | $139.17 |
| 52 Week High | $33.73 | $183.90 |
| Indicator | BXSL | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 51.00 | 38.72 |
| Support Level | $24.17 | $149.67 |
| Resistance Level | $24.88 | $169.38 |
| Average True Range (ATR) | 0.58 | 4.35 |
| MACD | 0.10 | -1.56 |
| Stochastic Oscillator | 70.00 | 20.34 |
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.